There’s always something going on in the world of lymphedema and lymphatic research! It can be a lot to keep up with, so here’s a digest of some of the latest headlines from this past summer carefully curated to keep you in the lymphie loop.


“HMC Lymphedema Department featured in prestigious journal”

Hamad Medical Corporation’s Oncology & Lymphedema Physiotherapy Department’s work to protect the vulnerable during COVID-19 has been featured in Rehabilitation Oncology Journal: “Our experience suggests that a hybrid system of face-to-face and tele/virtual consultations may provide an opportunity to improve accessibility to lymphedema care and reduce waiting time and may thereby become a sustainable model of care even after the pandemic,” says Noora Al Mudakha, Chief of Physiotherapy.

READ THE FULL ARTICLE AT THE PENINSULA QATAR.

“Orthocell (ASX:OCC) has breakthrough tissue engineering study published in US”

Regenerative medicine company Orthocell recently published a breakthrough tissue engineering study in PNAS. The study looked at combining Orthocell’s CelGro, a collagen membrane for regeneration procedures, with lymphatic and blood vessel cells to create functional lymphatic tissue.

“This study provides a new understanding of the role of CelGro in fabrication of tissue grafts for lymphatic vessel regeneration, which could have significant implications for a novel and effective surgical treatment of lymphedema,” Orthocell Chief Scientific Officer, Professor Minghao Zheng said.

READ THE FULL ARTICLE AT THE MARKET HERALD.

“King Edward VII’s new approach reduces damaging side effects of breast cancer surgeries”

Independent charitable hospital King Edward VII’s, based in Harley Street Medical Area, is incorporating new innovations to combat some of the damaging long-term side effects of breast cancer surgeries.

The lymphatic microsurgical healing approach (LYMPHA) redirects waste products from the lymphatic system into the veins. The technique has been demonstrated in several studies to significantly reduce the risk of breast cancer-related lymphedema.

READ THE FULL ARTICLE AT NEWS MEDICAL.

“Technion scientists have produced an engineered lymph vessel network”

Scientists at Technion have managed to grow an engineered human lymphatic vessel network, according to a press release. This development could lead to a better understanding of lymphatic vessel generation, which could have implications for the treatment of lymphedema.

READ THE FULL ARTICLE AT THE JERUSALEM POST.

“Deletion of single gene promotes growth of functional lymphatic valves”

A new preclinical study published in the Journal of Clinical Investigation indicates that targeting the gene Foxo1 may offer an early treatment approach for hereditary lymphedema.

“The later fibrosis stage of lymphedema cannot be massaged away,” said study principal investigator Ying Yang, PhD, assistant professor of molecular pharmacology and physiology at the University of South Florida Health Morsani College of Medicine. “Targeting lymph valves early in the disease is one critical aspect in identifying an effective treatment for lymphedema. If the disease progresses too far, it’s difficult to reverse.”

READ THE FULL ARTICLE AT USF HEALTH.

“Senators Gillibrand and Feinstein champion lymphatic disease (LD) inclusion in DOD research fund”

“We applaud the recent action of Senators Kirsten Gillibrand and Senator Dianne Feinstein and are hopeful that significant funding could become available to lymphatic researchers as a result,” said William Repicci, the President & CEO of Lymphatic Education & Research Network.

“This letter from the Senators represents significant progress toward the better future that we envision for all those living with lymphedema and other lymphatic diseases.”

READ THE FULL PRESS RELEASE AT EIN PRESSWIRE.

“U of A appoints new Kipnes chair in lymphatic disorders, paving the way for research to begin”

The University of Alberta has named Dr. Spencer Gibson as the new Dianne and Irving Kipnes Chair in Lymphatic Disorders.

As the inaugural chair, Gibson will head research to support the care of patients suffering under-reported, under-recognized, and under-diagnosed medical problems in the lymphatic system such as lymphedema.

“What spoke to me about [the role] was the ability to create a multidisciplinary team of researchers to tackle a problem that has been under-investigated in the past,” Gibson said. “It’s, I would say, about 10 years behind other diseases like cancer. So, this is an opportunity to create something new.”

READ THE FULL ARTICLE AT EDMONTON JOURNAL.


Lymphatic filariasis news

Lymphatic filariasis (commonly known as elephantiasis) is a neglected tropical disease caused by parasitic infection to the lymphatic system. It is the leading cause of lymphedema worldwide: of the over 120 million people infected, 40 million are incapacitated or disfigured by the disease.

“SMC’s work on curbing filariasis can be model for the country, finds study”

A study published in the BMC journal Infectious Diseases of Poverty finds that the implementation of the elimination of lymphatic filariasis program by Surat Municipal Corporation can become a model to develop guidelines and strategies to curb other diseases and infections in urban Indian settings.

READ THE FULL ARTICLE AT TIMES OF INDIA.

“Imidido Or Podoconiosis, New Hope For Sufferers”

Through organizations like Heart and Sole Africa, sufferers of neglected tropical diseases are able to receive treatment: “It is a free treatment. But still, victims don’t come for medication because of stigma,” says clinic coordinator Marie Jose Dukuzimana.

“To get these patients, we conduct campaigns in churches, schools, and other public places.”

READ THE FULL ARTICLE AT KT PRESS RWANDA.

“To Improve Global Health Security, We Must Not Abandon Tackling Existing Epidemics”

Neglected tropical diseases (NTDs) like blinding trachoma, leprosy, intestinal worms, and elephantiasis are preventable and treatable, yet they still affect 1.7 billion people around the world.

Over 600 million people in Africa require treatment for an NTD, making up 35% of the global burden. Across the continent, 12 countries are on track to eliminate an NTD in the next three years – an extraordinary feat based on years of necessary action. But the UK government’s recent exit from supporting NTD programs, particularly during a pandemic, undermines years of progress and will deeply impact millions of Africans.

READ THE FULL ARTICLE AT IPS NEWS.

“BU Students’ Hackathon-Winning Project Could Help Combat a Neglected Tropical Disease”

“Spread truth, not disease”: Four Boston University students create a pill pack designed to combat misinformation surrounding lymphatic filariasis—and help prevent the disease.

For their concept, the team won $500 apiece and the opportunity to virtually present their winning project to neglected tropical disease experts at the Coalition for Operational Research on Neglected Tropical Diseases annual conference in November.

READ THE FULL ARTICLE AT BU TODAY.

“138m Nigerians at risk of lymphatic disease – Expert”

No fewer than 138 million Nigerians are at risk of lymphatic filariasis (LF) and if not addressed, may develop elephantiasis, says Emmanuel Davies, the Deputy Director/Programme Manager of the National LF Elimination Programme, Federal Ministry of Health Nigeria.

He said there was need for mass administration of medicines of the at-risk population area in Nigeria: “Morbidity Management and Disability Prevention (MMDP) must be activated in states to ensure affected persons have basic healthcare, we must guide against mosquito bite.”

READ THE FULL ARTICLE AT VANGUARD NEWS.

“Gates Foundation working with Centre to eliminate elephantiasis through triple drug therapy”

The Bill and Melinda Gates Foundation is working with the Indian government to accelerate the elimination of lymphatic filariasis, commonly known as elephantiasis, through the nationwide roll-out of a triple-drug therapy.

Dr. Helen Jamet, Deputy Director, Vector Control, Malaria at Bill & Melinda Gates Foundation, said that the National Vector Borne Disease Control Programme and the State governments are scaling up the program with increased resources. “Screening and surveillance are the key to preventing reintroduction of lymphatic filariasis infection in large urban areas which provide ideal breeding sites for the vectors.”

READ THE FULL ARTICLE AT THE HINDU.

“Why it’s hard to end elephantiasis, a debilitating disease spread by mosquitoes”

Barriers to eradication of elephantiasis are not straightforward. Research and interventions have been overwhelmingly biomedical, focusing largely on mass drug administration (ivermectin, albendazole, diethycarbarmazine). Drugs work by killing the larval stages of the parasites. However, these drugs can only save a person from disfigurement if they are taken early and regularly.

Placing the illness in the context of the local culture is still a major challenge for health practitioners. Gender dynamics can also be an important factor in seeking treatment.

READ THE FULL ARTICLE AT THE CONVERSATION.


Compressed News

June 2021

July 2021

Former University of Maryland gymnast Alexandra Robinson plans surgery to combat lymphedema.

August 2021

Theresa is proud of her lipo-lymphedema.

For more articles about lymphedema and lymphatic research, follow The Lymphie Life on Facebook and Twitter!